JOP20150008B1 - أجسام مضادة ل vista وأجزاء منها - Google Patents

أجسام مضادة ل vista وأجزاء منها

Info

Publication number
JOP20150008B1
JOP20150008B1 JOP/2015/0008A JOP20150008A JOP20150008B1 JO P20150008 B1 JOP20150008 B1 JO P20150008B1 JO P20150008 A JOP20150008 A JO P20150008A JO P20150008 B1 JOP20150008 B1 JO P20150008B1
Authority
JO
Jordan
Prior art keywords
fragments
methods
vista antibodies
vista
andnbsp
Prior art date
Application number
JOP/2015/0008A
Other languages
English (en)
Inventor
Gordon Powers
Linda Snyder
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2014/002868 external-priority patent/WO2015097536A2/en
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of JOP20150008B1 publication Critical patent/JOP20150008B1/ar

Links

Abstract

يتعلق الاختراع الحالي بأجسام مضادة جديدة وأجزاء منها ترتبط بالكابت Ig ذي الحقل V لتنشيط الخلايا التائية (VISTA)، وطرق لتصنيعها واستخدامها. وتتضمن طرق الاستخدام طرقاً لمعالجة السرطان، بما في ذلك اللوكيميا، الليمفومة، الأورام الصلبة والورم الجلدي.
JOP/2015/0008A 2014-11-26 2015-01-19 أجسام مضادة ل vista وأجزاء منها JOP20150008B1 (ar)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462085086P 2014-11-26 2014-11-26
PCT/IB2014/002868 WO2015097536A2 (en) 2013-12-24 2014-12-22 Anti-vista antibodies and fragments
US201562101352P 2015-01-08 2015-01-08

Publications (1)

Publication Number Publication Date
JOP20150008B1 true JOP20150008B1 (ar) 2021-08-17

Family

ID=56754897

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2015/0008A JOP20150008B1 (ar) 2014-11-26 2015-01-19 أجسام مضادة ل vista وأجزاء منها

Country Status (2)

Country Link
JO (1) JOP20150008B1 (ar)
TW (2) TWI684601B (ar)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10899836B2 (en) * 2016-02-12 2021-01-26 Janssen Pharmaceutica Nv Method of identifying anti-VISTA antibodies
JP7211961B2 (ja) * 2017-03-14 2023-01-24 ファイヴ プライム セラピューティクス インク 酸性ｐＨでＶＩＳＴＡに結合する抗体
KR102281405B1 (ko) * 2017-10-20 2021-07-26 주식회사 파멥신 항-vista 항체 및 이의 용도
GB202108446D0 (en) * 2021-06-14 2021-07-28 Hummingbird Bioscience Holdings Pte Ltd Cells expressing VISTA antigen-binding molecules

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013277051B2 (en) * 2012-06-22 2018-06-07 King's College London Novel VISTA-Ig constructs and the use of VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders

Also Published As

Publication number Publication date
TWI684601B (zh) 2020-02-11
TW202237665A (zh) 2022-10-01
TW202017946A (zh) 2020-05-16
TW201619195A (zh) 2016-06-01
TWI770455B (zh) 2022-07-11

Similar Documents

Publication Publication Date Title
PH12016501244A1 (en) Anti-vista antibodies and fragments
PH12018500906A1 (en) Antibodies specifically binding pd-1 and their uses
PH12017502180A1 (en) Tau-binding antibodies
MX2017016647A (es) Anticuerpos y fragmentos anti-vista.
PH12016501763A1 (en) Multispecific antibodies
GEP20227343B (en) Anti-lag3 antibodies and antigen-binding fragments
PH12017500002A1 (en) Anti-cdh6 antibody drug conjugates
TW201613648A (en) Compounds and compositions for immunotherapy
GEP20217331B (en) Anti-tigit antibodies
NZ731467A (en) Anti-tim3 antibodies and methods of use
MX2018002166A (es) Conjugados anticuerpo anti-dll3-farmaco y metodos de uso.
MX2016004570A (es) Uso de inhibidores del bromodominio de cbp/ep300 para la inmunoterapia del cáncer.
PH12016502061A1 (en) Novel antii-rnf43 antibodies and methods of use
MY193677A (en) Tau-binding antibodies
PH12017500406A1 (en) Novel anti-mfi2 antibodies and methods of use
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
MX2018006249A (es) Nuevos anticuerpos anti-emr2 y metodos de uso.
MX2016015163A (es) Biomarcadores mit y metodos para su uso.
JOP20150008B1 (ar) أجسام مضادة ل vista وأجزاء منها
MX2018005987A (es) Compuestos heterociclicos para el tratamiento de enfermedades.
MX2018007817A (es) Nuevos anticuerpos anti-mmp16 y metodos para su uso.
MX2018007818A (es) Anticuerpos dirigidos contra upk1b novedosos y metodos para su uso.
JOP20200184A1 (ar) أجسام مضادة لـ vista وأجزاء منها